Extracorporeal membrane oxygenation ECMO system: Uses, Safety, Operation, and top Manufacturers & Suppliers

Introduction

Extracorporeal membrane oxygenation ECMO system is a high-acuity, resource-intensive form of extracorporeal life support used in critical care to temporarily support gas exchange (oxygenation and carbon dioxide removal) and/or circulatory function when conventional therapies are insufficient. It is not a single part, but a complete clinical device ecosystem: a console, pump, membrane oxygenator, tubing circuit, cannulas, sensors, alarms, and the trained team and protocols required to operate it safely.

For hospital leaders and frontline teams, ECMO matters because it can expand a facility’s capability to manage severe respiratory failure, cardiogenic shock, and selected peri-arrest scenarios—while also introducing significant operational demands: specialized staffing, consumable supply chains, blood-contacting disposables, infection prevention requirements, and around-the-clock monitoring. For biomedical engineering and procurement teams, it also brings a different risk profile than many other types of hospital equipment: rapid failure escalation, complex human factors, and stringent service readiness expectations.

This article provides practical, non-brand-specific guidance on how an Extracorporeal membrane oxygenation ECMO system is used, what safe operation looks like, what to verify before starting, how outputs are typically interpreted, what to do when problems arise, and how cleaning/infection control is commonly approached. It also includes a global market snapshot and a structured view of manufacturers, OEM relationships, and distribution models—written for administrators, clinicians, biomedical engineers, and procurement/operations leaders.

Although ECMO is sometimes discussed alongside cardiopulmonary bypass (CPB) used in operating rooms, the operational reality is different. CPB is typically short-duration and tightly controlled within a surgical workflow, while ECMO is designed for continuous support over prolonged periods in an ICU environment where the patient may undergo imaging, bedside procedures, transports, and multiple handoffs. That “ICU reality” makes system reliability, alarm response discipline, and infection control practices particularly central to safe outcomes.

From a governance perspective, many institutions treat ECMO as a service line rather than merely a device purchase. Mature programs often include structured credentialing, simulation-based training, case review processes, and defined escalation pathways for rare events. For administrators, this framing helps align budgets (console + disposables + staffing), clarify accountability, and set realistic expectations for what can be delivered safely—especially during demand surges when blood products, staffing, and ICU beds become limiting resources.

What is Extracorporeal membrane oxygenation ECMO system and why do we use it?

An Extracorporeal membrane oxygenation ECMO system is a medical device platform that circulates blood outside the body through a membrane oxygenator to exchange gases (add oxygen, remove carbon dioxide) and then returns blood to the patient. Depending on configuration and cannulation strategy, the system may provide primarily respiratory support, primarily circulatory support, or a combination of both.

ECMO is commonly referred to as part of extracorporeal life support (ECLS). In practice, “ECMO system” can mean both the hardware and the clinical processes that make extracorporeal support possible: standardized setup, anticoagulation management, patient monitoring, and emergency procedures. This is one reason ECMO procurement discussions often include training, protocols, and service readiness as contractual deliverables—not optional add-ons.

Core purpose (in plain terms)

• Buy time: ECMO is typically used as a temporary support strategy while underlying disease is treated, recovery occurs, or a bridge pathway is determined (for example, to another therapy).
• Offload injured organs: It can reduce reliance on aggressive ventilator settings in severe lung dysfunction, and it can augment perfusion in severe cardiac dysfunction.
• Enable complex care pathways: It can support high-risk transport within or between facilities, selected procedural scenarios, and specialized critical care programs.

Common ECMO configurations (high-level)

Programs usually describe ECMO support by the drainage site and return site (the cannulation configuration), because this drives the type of physiologic support delivered:

• Venovenous (VV) ECMO: blood is drained from the venous system and returned to the venous system. This configuration is commonly used when the primary problem is gas exchange (oxygenation/CO₂ removal) and the heart’s pumping function is relatively preserved. VV configurations may use two cannulas (drainage + return) or a single dual-lumen cannula in selected workflows.
• Venoarterial (VA) ECMO: blood is drained from the venous system and returned to the arterial system. This configuration can provide both gas exchange and circulatory support, and it is commonly used in cardiogenic shock pathways or severe combined cardio-respiratory failure. Cannulation can be peripheral (commonly via femoral vessels) or central (program- and scenario-dependent).
• Hybrid configurations (examples: VAV, VV-A, VA-V): some centers use hybrid strategies to address complex mixing or perfusion issues, but these require advanced expertise, monitoring, and governance. Naming conventions vary, so clear documentation and line tracing are essential during handoffs.

Another related category sometimes encountered in procurement discussions is extracorporeal CO₂ removal (ECCO₂R), which may use lower blood flows than full ECMO in selected scenarios. ECCO₂R is not interchangeable with ECMO and typically has different indications, circuit requirements, and risk profiles; facilities should avoid assuming “ECMO capability” automatically covers ECCO₂R pathways without separate training and policy.

Where you commonly see it in hospitals

• Adult, pediatric, and neonatal ICUs in tertiary or quaternary care centers
• Cardiac surgery/perfusion environments (especially when transitioning between operating room and ICU workflows)
• Emergency department and catheterization lab pathways in selected centers with established protocols
• Inter-facility transport/retrieval programs using portable consoles (capability varies by manufacturer)

What the system typically includes

While designs vary by manufacturer, the “system” usually comprises:

• Console with user interface, power management, and alarm logic
• Blood pump (commonly centrifugal) to generate circuit flow
• Membrane oxygenator (hollow-fiber) often with integrated heat exchange capability (varies by manufacturer)
• Tubing pack/circuit with connectors, sampling ports, and safety clamps
• Cannulas (drainage and return) selected by clinical team and patient factors
• Sensors/monitors (commonly flow, pressure, temperature, bubble/air detection; optional venous saturation or hematocrit monitoring varies by manufacturer)
• Sweep gas supply (oxygen/air blend) connected to the oxygenator gas side

Additional components that may be relevant depending on your program design include:

• Biocompatible circuit coatings intended to reduce blood-material interaction (selection and performance are protocol-dependent).
• Circuit holders and secure mounting solutions (cart-based, bed-mounted, or transport stretcher mounting), which matter for line tension risk and transport safety.
• Gas exhaust management accessories (program-dependent): some environments consider routing oxygenator exhaust away from staff breathing zones or enclosed spaces, especially when condensation can drip or contaminate nearby surfaces.
• Integration points for adjunct therapies (strictly per IFU and program protocol): for example, sampling manifolds, pressure monitoring ports, or interfaces that support coordinated operation alongside renal replacement therapy equipment.

Key benefits (clinical and operational)

• Physiologic support beyond conventional methods in selected severe failure scenarios
• Portable, standardized platforms can improve consistency across units when coupled with checklists and trained teams
• Integrated monitoring and alarms can support early detection of circuit issues (though it never replaces direct clinical assessment)
• Program development advantages: an ECMO service often drives broader improvements in critical care governance, simulation training, and emergency preparedness

ECMO is also among the most complex pieces of medical equipment used in acute care. Its benefits depend heavily on patient selection, team capability, and disciplined operations—making training, maintenance readiness, and safety culture inseparable from the technology.

When should I use Extracorporeal membrane oxygenation ECMO system (and when should I not)?

Use decisions for Extracorporeal membrane oxygenation ECMO system are clinical and protocol-driven, typically made by specialized teams. The points below are general, non-prescriptive patterns seen in ECMO programs, not medical advice.

Common scenarios where ECMO may be considered (program-dependent)

• Severe respiratory failure where optimized conventional support is not achieving adequate gas exchange
• Cardiogenic shock with inadequate perfusion despite appropriate escalation of standard therapies
• Post-cardiotomy or peri-procedural decompensation in centers with established cardiac surgery/perfusion support pathways
• Bridge strategies (for example, to recovery, decision-making, transplant evaluation, or other mechanical support), depending on local policy
• Selected cardiac arrest pathways (ECPR) in highly structured programs with strict inclusion criteria and rapid-response logistics
• Specialty use cases such as support during high-risk airway/respiratory procedures or transport of unstable patients, where capability and governance are mature

Whether these use cases are appropriate depends on facility readiness, staffing, cannulation expertise, blood bank support, imaging capability, and intensive monitoring capacity.

Many programs emphasize early consultation rather than “last-minute rescue,” because cannulation logistics, blood product preparation, and imaging support can take time. Operationally, early activation can also prevent rushed setup—one of the most common contributors to omission errors (missing clamps, incorrect sensor placement, incomplete de-airing, or undocumented alarm changes).

Situations where it may not be suitable (high-level, non-clinical framing)

ECMO may be inappropriate when the program cannot provide safe delivery or when the likely benefit is limited. Examples of broad categories include:

• No viable bridge or recovery pathway (for example, irreversible pathology without an agreed goal of care)
• Inability to provide required monitoring and staffing (ECMO is not a “set-and-forget” therapy)
• High risk from required anticoagulation or inability to manage bleeding/thrombotic balance (managed clinically; suitability varies case by case)
• Advanced multi-organ failure or severe injury where outcomes are poor and resources may be better used elsewhere (requires multidisciplinary, ethical review)
• Anatomical/vascular access limitations that prevent safe cannulation or adequate flows
• Lack of support services (perfusion/ECMO specialist coverage, imaging, laboratory turnaround, surgical backup, and blood product availability)

In addition to patient-related factors, institutions sometimes consider system-level constraints when deciding whether ECMO can be offered safely at a given moment (for example, limited trained staffing for continuous bedside coverage, lack of available ICU beds, or supply chain disruption affecting oxygenator/cannula availability). These considerations are not “rationing by convenience”; rather, they reflect the reality that incomplete support capacity increases harm risk.

Safety cautions and general contraindication themes (non-prescriptive)

• Blood-contacting circuit risks: bleeding, thrombosis, hemolysis, air embolism, and inflammatory responses are intrinsic hazards.
• Device dependence: power, oxygen supply, tubing integrity, and alarm response must be robust at all times.
• Human factors: workload, handoffs, alarm fatigue, and variable team experience are common failure contributors.
• Resource intensity: ECMO impacts ICU bed utilization, staffing ratios, and consumables (oxygenators, circuits, cannulas), and it can strain supply chains during surges.

The safest programs translate these realities into clear governance: defined inclusion/exclusion pathways, escalation triggers, transport policies, and “stop rules” aligned with manufacturer guidance and facility risk management.

What do I need before starting?

Successful and safe ECMO use is primarily an operational achievement: the right environment, the right accessories, and a trained team using standardized processes. Specific requirements vary by manufacturer and local policy.

Facility and environment readiness

• Appropriate care setting: ICU or procedural environment with continuous monitoring, trained staff, and rapid response capability.
• Reliable power: grounded outlets, backup power strategy, and routine battery health checks for the console.
• Medical gas availability: oxygen (and often air) for sweep gas, with a plan for transport cylinders if moving the patient.
• Space and ergonomics: enough room to position the console safely, route tubing without kinks, and maintain access to the patient.
• Emergency readiness: crash cart access, suction, and predefined emergency ECMO response roles.

A practical readiness detail that is sometimes overlooked is time synchronization and documentation workflows. When device logs, patient monitors, infusion pumps, and laboratory timestamps do not align, incident review and performance troubleshooting become harder. Some centers include “clock check” as part of go-live commissioning.

Required accessories and consumables (typical categories)

• Disposable ECMO circuit/tubing pack
• Membrane oxygenator compatible with the console and expected support mode
• Cannulas (drainage/return) and securement supplies
• Connectors and clamps approved for blood-contacting use
• Sampling supplies and labeling for traceability
• Sensors (flow probes, pressure transducers, temperature probes; optional saturation monitoring varies by manufacturer)
• Heater/cooler interface if used (integrated or external; varies by manufacturer)
• Spare critical components per risk assessment (for example: backup oxygenator, pump head, clamps, batteries, power cords)

Procurement teams often find that the “kit completeness” problem is real: the clinical device may arrive, but missing connectors, gas fittings, or compatible disposables can delay readiness. Standardized bill-of-materials and par-level management reduce this risk.

Many facilities also build an ECMO “grab-and-go” accessory kit that stays sealed and checked on a schedule. Typical contents include spare clamps, pressure transducer sets, cable ties/securement materials, emergency caps, and clearly labeled tools for circuit management. The objective is not to create a second inventory stream, but to ensure that high-risk “small parts” are always immediately available during urgent initiation or transport.

Clinical support services and logistics (often required for safe delivery)

Even when the console and disposables are available, ECMO initiation and ongoing management commonly depends on additional services:

• Blood bank readiness: access to blood products and a plan for urgent crossmatch and product delivery, aligned with clinical protocol.
• Rapid laboratory turnaround: blood gases and coagulation monitoring often drive clinical adjustments; delays can increase risk.
• Imaging capability: ultrasound and/or radiography support for access, cannula position confirmation, and complication evaluation (program-dependent).
• Surgical and procedural backup: defined pathways for cannula repositioning, vascular complications, or escalation to alternate access strategies if required.
• Pharmacy support: standardized medication preparation and compatibility guidance for high-acuity infusions commonly used in ECMO patients.
• Transport and security/logistics support: elevator access, route planning, and rapid-response staffing when moving ECMO patients through public corridors or between buildings.

Training and competency expectations

• Role-based training: cannulation and clinical management are typically physician-led; circuit management may be performed by perfusionists or trained ECMO specialists (varies by region).
• Initial competency and ongoing validation: simulation, annual skills checks, and emergency drills (air entrainment, pump failure, oxygenator failure) are common.
• Human factors training: closed-loop communication, checklist discipline, and structured handoffs reduce high-risk variability.

A useful program maturity marker is training coverage beyond the “core ECMO team.” Radiology, respiratory therapy, ICU float nurses, transport teams, and even environmental services may need targeted orientation on what not to do around an ECMO circuit (for example, avoiding line tension, not disconnecting gas fittings, and understanding which alarms require immediate escalation).

Pre-use checks and documentation (typical best practices)

• Confirm device service status and preventive maintenance is current (biomedical engineering responsibility).
• Verify disposable integrity: packaging intact, correct sizes, lot/serial numbers recorded, and within expiration dates.
• Perform system self-tests and sensor zeroing/calibration as applicable (varies by manufacturer).
• Verify alarm configuration aligns with facility policy and patient context (document any deviations per protocol).
• Confirm sweep gas setup and oxygen source, and verify the oxygen analyzer function if used.
• Ensure traceability: record console ID/serial, oxygenator lot, tubing lot, and cannula identifiers in the patient record and device log.

In addition, many centers include these pre-use verifications to reduce “surprises” during initiation:

• Confirm the console has a known-good battery and that battery capacity checks are documented on a schedule (runtime varies by model, age, and load).
• Verify availability of backup sweep gas delivery components (regulators, spare tubing, and a compatible connector set) for transport scenarios.
• Confirm a spare oxygenator/circuit exchange plan, including where spares are stored and who is authorized to perform an emergent changeout.

How do I use it correctly (basic operation)?

The exact workflow for an Extracorporeal membrane oxygenation ECMO system is manufacturer-specific and should follow the Instructions for Use (IFU) and facility policy. The outline below describes a common, high-level sequence used in ECMO programs.

1) Team briefing and role assignment

Before any setup or patient connection:

• Confirm mode intent (for example, respiratory vs circulatory support) and expected monitoring plan.
• Assign roles: cannulation lead, circuit lead, medication/infusion lead, documentation lead, and runner.
• Review emergency actions for air, low flow, power loss, and oxygen supply failure.

Programs that perform transports or emergent cannulation often add a “line-tracing lead” role during initiation and handoffs. This person is responsible for visually confirming, out loud, that drainage and return paths are correct and that clamp placement is understood by the entire team.

2) Assemble the circuit (as per IFU)

• Use only compatible, approved disposables for the console and pump/oxygenator.
• Route tubing to avoid torsion, sharp bends, or stress on connectors.
• Install sensors (flow, pressure, temperature) in the correct orientation and locations.

At assembly time, disciplined labeling can prevent future errors: many teams label drainage and return limbs, mark flow direction arrows on tubing (where appropriate), and standardize the physical layout (console position and tubing routing) so staff moving between beds see the same configuration every time.

3) Prime and de-air

Priming steps vary by manufacturer and local protocol, but generally include:

• Fill the circuit with approved priming fluid.
• Remove air meticulously from the oxygenator and tubing.
• Confirm secure connections and absence of leaks.
• Maintain a clean field and manage sharps to reduce contamination and injury risk.

Air management is not a one-time step; it is an ongoing mindset. During priming and initial recirculation, teams often visually inspect for microbubbles, check that sampling ports are closed, and ensure that any stopcocks are positioned correctly. Facilities commonly standardize how clamps are staged so that if a connection must be secured quickly, everyone knows which clamp to reach for and where it is located.

4) Connect sweep gas and verify gas-side function

• Connect the sweep gas source to the oxygenator gas inlet.
• Confirm the gas blender (if used) is functioning and that setpoints are visible.
• Verify that oxygen supply is adequate for anticipated duration, especially for transport.

In addition to inlet setup, some programs explicitly plan for gas exhaust management. Oxygenator exhaust can create condensation and may contain high oxygen concentrations; keeping exhaust ports unobstructed and routed away from sensitive surfaces helps reduce contamination and environmental risk, especially in enclosed transport situations.

5) Verify console readiness and alarms

• Confirm the console completes self-checks.
• Confirm battery status and that AC power is connected and stable.
• Ensure alarms for flow/pressure/air detection are active and audible per policy (exact alarm types vary by manufacturer).

6) Initiate recirculation (pre-connection)

Many programs start the circuit in a safe recirculation configuration to confirm:

• Stable pump function
• Accurate sensor readings
• No vibration, abnormal noise, or unexpected heating
• No visible microbubbles or foaming

If your facility uses standardized documentation, capturing the “recirculation baseline” (flow, pressures, RPM, temperature) can help differentiate later patient-related changes from device or sensor problems.

7) Patient connection (performed by trained clinicians)

Cannulation and connection are high-risk steps that require trained teams and sterile technique. Operationally, this typically includes:

• Confirming correct circuit orientation (drainage vs return)
• Using clamps appropriately during connection to prevent air ingress
• Securing cannulas and tubing to prevent accidental decannulation or kinking

8) Initiate support and stabilize

• Start at conservative support levels and adjust per protocol and clinical response.
• Closely monitor flows, pressures, oxygenation/ventilation parameters, and hemodynamics.
• Document baseline console values for trend comparison.

Many programs also verify early performance with a structured “first-hour checklist,” which may include confirmation of cannula securement, line tracing, verification of adequate sweep gas delivery, and assessment of oxygenator function using a combination of device readings and clinical/laboratory data (program-dependent).

9) Ongoing surveillance and routine tasks (shift-based discipline)

After initiation, safe ECMO management commonly relies on consistent, repeatable routines:

• Perform regular circuit inspections (tubing integrity, connector security, visible clot, condensation, and secure positioning).
• Trend key values (flow, pressures, delta pressure, sweep settings) and document changes with time and reason.
• Re-check alarm settings after patient moves, console repositioning, power transitions, or software/configuration changes.
• Confirm that emergency items (clamps, spare connectors, backup oxygen source) remain at the bedside or on the transport cart as defined by policy.

Typical settings and what they generally mean (conceptual)

Values and targets vary widely by patient, mode, and manufacturer. In general terms:

• Blood flow (L/min): the amount of blood the pump is moving; relates to the level of support delivered.
• Pump speed (RPM): how fast the pump is turning; the relationship between RPM and flow depends on resistance, drainage, and cannula position.
• Sweep gas flow: primarily influences carbon dioxide removal; increasing sweep typically increases CO₂ clearance (within system limits).
• Gas oxygen fraction: influences oxygen transfer across the oxygenator, but patient oxygenation also depends on blood flow, hemoglobin, and mixing dynamics.
• Pre- and post-oxygenator pressures / delta pressure: rising pressure drop across the oxygenator can indicate clot burden or flow limitation (interpretation is system- and context-dependent).
• Venous drainage pressure: excessive negative pressures can contribute to hemolysis or suction events (thresholds vary by manufacturer and protocol).
• Temperature: if heat exchange is used, temperature control must be coordinated with overall ICU temperature management.

How do I keep the patient safe?

Keeping a patient safe on ECMO is a combined effort across clinical decision-making, disciplined device operation, and organizational controls. The Extracorporeal membrane oxygenation ECMO system itself provides monitoring and alarms, but safe outcomes depend on the team’s ability to interpret and respond reliably.

Safety fundamentals that scale across brands and countries

• Standardization: use checklists for setup, initiation, shift handover, transport, and emergencies.
• Redundancy: ensure backup power, backup oxygen supply, spare disposables, and a rapid pathway for circuit exchange when needed.
• Closed-loop communication: announce actions (clamping, changing sweep, moving the console) and confirm read-back.
• Traceability: lot/serial tracking supports recall management and incident investigation.

Monitoring practices (typical categories)

Monitoring is mode- and program-dependent, but commonly includes:

• Patient monitoring: hemodynamics, oxygenation, ventilation markers, temperature, neurologic status, and laboratory trends.
• Circuit monitoring: flow, pressures, delta pressure across oxygenator, visible clot/condensation, and integrity of connections.
• Gas-side monitoring: sweep source, oxygen concentration if used, and adequacy of supply for transport.
• Blood compatibility signals: hemolysis indicators, coagulation status, and signs of thrombus formation (interpreted clinically).

Common complication themes to proactively manage (operational lens)

Programs usually build safety controls around predictable risk clusters, even though management details are clinical:

• Bleeding and thrombosis balance: anticoagulation protocols, laboratory turnaround, and clear escalation criteria reduce variability and delays.
• Hemolysis and suction events: careful attention to drainage pressures, cannula position, and volume/flow dynamics (per protocol) can reduce mechanical blood trauma risk.
• Oxygenator performance deterioration: trending delta pressure and gas exchange performance helps detect early changes before crisis-level failure.
• Vascular access complications: securement, frequent site checks, and clear documentation of cannula size/location support early detection of problems.
• Neurologic and mobility risks: structured sedation practices, delirium prevention, and (where appropriate) mobilization protocols require coordination so tubing and cannulas are protected during patient movement.
• Infection risk: cannulation sites, frequent line access for sampling, and high-touch console surfaces require consistent aseptic and cleaning routines.

Alarm handling and human factors

• Treat alarms as a prompt for assessment, not a diagnosis.
• Use a structured response: check the patient first, then the circuit, then the console/sensors.
• Prevent alarm fatigue by aligning alarm limits with facility policy, verifying defaults after updates, and documenting any temporary adjustments.
• Train for “rare but catastrophic” events: air entrainment, pump stoppage, oxygenator failure, and accidental decannulation.

High-risk moments to manage tightly

• Cannulation/decannulation and any circuit break-in
• Patient transport (intra-hospital or inter-facility): secure equipment, verify battery runtime, verify gas cylinders, and rehearse elevator/doorway constraints
• Shift changes and handoffs: structured bedside handover that includes circuit inspection and line tracing
• Procedures at bedside: avoid line tension, keep circuit away from sterile fields unless planned, and clarify who “owns” the ECMO console during procedures

Always follow the manufacturer’s IFU and your facility’s ECMO governance framework. Where guidance differs, resolve conflicts through a formal risk assessment rather than informal workarounds.

How do I interpret the output?

An Extracorporeal membrane oxygenation ECMO system generates device outputs (console values, sensor readings, alarms) that must be interpreted alongside patient data. Device numbers are best treated as trend tools that help detect deviation from baseline and prompt timely assessment.

Common device outputs you may see

Depending on manufacturer and configuration, outputs may include:

• Flow (measured or calculated)
• Pump speed (RPM) and pump power/load
• Pressures (drainage pressure, pre-oxygenator, post-oxygenator)
• Delta pressure across the oxygenator
• Temperature (circuit and/or patient probe interfaces)
• Venous oxygen saturation (if integrated monitoring is present)
• Air/bubble detection status (if available)
• Battery and power status
• Gas settings display (sweep flow, oxygen fraction), sometimes via external blender rather than console

How clinicians typically interpret these outputs (general approach)

• Flow vs clinical effect: flow indicates potential support delivery, but actual oxygen delivery depends on hemoglobin, saturation, and patient demand.
• Pressure patterns: changes in drainage or return pressures can signal cannula position issues, volume status changes, kinks, clot burden, or patient movement effects.
• Delta pressure trends: a gradual rise may raise suspicion for oxygenator resistance changes; interpretation should be combined with gas exchange performance and visual inspection.
• Gas exchange assessment: device settings help, but performance is usually confirmed with laboratory data and clinical status rather than console display alone.

Trend patterns that often prompt evaluation (non-diagnostic examples)

The table below is intentionally generic. It is not a troubleshooting protocol, but an example of how teams use trends to decide when to look closer.

Observed pattern (trend)	What it may suggest (context-dependent)	Typical first checks (operational)
Flow decreases while RPM stays the same	Drainage limitation, obstruction, patient movement effect, or sensor issue	Check for kinks/clamps, line tension, cannula position cues, sensor connections/zeroing
RPM increases over time to maintain the same flow	Increasing circuit resistance or drainage challenges	Review pressures and delta pressure trend, inspect oxygenator/tubing for clot or obstruction, verify cannula securement
Delta pressure rises with stable flow	Oxygenator resistance change (possible clot burden)	Visual inspection, compare pre/post oxygenator performance per protocol, confirm pressure transducers are functioning
Bubble/air alarm or visible air	Air entry or detection artifact	Treat as urgent per policy, inspect connections/ports, verify sensor placement and circuit integrity
Sweep unchanged but CO₂ control worsens clinically	Gas-side delivery issue, oxygenator performance change, or increased patient demand	Confirm sweep source and tubing, verify gas flowmeter/blender function, check for water/condensation issues per protocol

Common pitfalls and limitations

• Sensor drift or misplacement: flow and pressure sensors can give misleading values if incorrectly positioned, disconnected, or not zeroed per protocol.
• Recirculation and mixing effects: oxygenation values can be affected by how blood returns and mixes (especially relevant in different ECMO modes).
• Over-reliance on a single number: ECMO safety depends on multi-parameter assessment and trend review.
• Documentation gaps: missing baseline values make it harder to detect subtle deterioration in oxygenator performance or circuit resistance.

For administrators and biomedical engineers, these limitations reinforce why training and standardized documentation are not “nice to have”—they are core risk controls for this class of hospital equipment.

What if something goes wrong?

Failures on ECMO can escalate quickly. A structured troubleshooting mindset improves safety: patient first, circuit second, console third, while maintaining clear team communication.

Quick troubleshooting checklist (generic, non-brand-specific)

• Confirm the patient’s immediate status and call for additional help per protocol.
• Check for obvious circuit issues: kinks, clamps, disconnections, tension on cannulas, or visible air.
• Verify adequate power: AC connected, battery status, and no loose cables.
• Confirm pump is running and that displayed flow matches clinical expectations (consider sensor error).
• Assess drainage and return pressures for signs of obstruction, suction, or malposition (interpret per protocol).
• Verify sweep gas source: cylinder pressure/wall supply, blender function, and tubing connections.
• Review oxygenator performance: changes in delta pressure, visible clot, condensation on gas side, or reduced gas exchange.
• Confirm alarms are audible and that alarm limits are appropriate and not inadvertently muted.
• Re-check recent events: repositioning, transport, bedside procedure, line changes, or fluid shifts.
• Document the event, actions taken, and response, including device values before/after.

Common scenarios and what teams often check first (high-level)

Because ECMO systems are tightly coupled to patient physiology, the same alarm can have different causes. The goal is to rapidly rule out the most dangerous and most reversible problems.

• Low-flow states: teams often look for line obstruction (kinks/clamps), cannula malposition cues, patient movement effects, and suction/drainage limitation patterns on pressures (per protocol).
• Suction/chattering events: commonly trigger a rapid assessment of venous drainage adequacy, cannula position stability, and whether recent patient handling or volume shifts occurred.
• Gas exchange concerns: frequently prompt verification of sweep gas source continuity, flowmeter/blender function, and oxygenator condition, along with laboratory confirmation.
• Unexpected console faults: often lead to immediate checks of power stability, cable integrity, and whether the unit recently transitioned between AC power and battery.

Facilities that run regular simulations often assign a dedicated “documentation and timekeeper” during emergencies, because accurate timestamps and recorded device values can be critical for post-event review, manufacturer escalation, and regulatory reporting.

When to stop use (general operational framing)

Stopping ECMO is a clinical decision guided by protocols and goals of care. Operationally, immediate emergency actions may be required when there is an imminent threat that cannot be rapidly mitigated (for example, uncontrolled air entrainment or catastrophic circuit failure). Facilities should have predefined emergency procedures that specify who leads, what is clamped, what backup equipment is used, and how the incident is documented.

When to escalate to biomedical engineering or the manufacturer

Escalate promptly when:

• The console shows recurrent faults, unexpected shutdowns, or battery/power anomalies.
• Sensors repeatedly fail calibration or produce inconsistent readings.
• There is suspected device damage, fluid ingress, or overheating.
• Alarms or displays behave inconsistently after software updates or configuration changes.
• You suspect a defect that could affect other units (triggering fleet checks and potential regulatory reporting).

From a governance standpoint, ensure events are routed through your incident reporting system, and preserve relevant disposables/parts if your policy supports investigation (while maintaining biohazard safety). When possible within policy and local regulation, retaining device screenshots, alarm codes, and console event logs can significantly speed technical diagnosis.

Infection control and cleaning of Extracorporeal membrane oxygenation ECMO system

Infection prevention for ECMO is both a device issue and a care-process issue. The Extracorporeal membrane oxygenation ECMO system includes disposable, blood-contacting components and reusable console surfaces; each requires different controls.

Cleaning principles (what usually applies)

• Follow the manufacturer’s IFU for approved cleaning agents and methods; chemical compatibility varies by manufacturer.
• Assume high contamination risk: ECMO is used in critical care environments with frequent touch points and exposure to bodily fluids.
• Do not reprocess single-use disposables unless explicitly validated and permitted by local regulation and the manufacturer (often not permitted).
• Prevent fluid ingress into the console: avoid spraying directly into vents, seams, connectors, or screens.

In addition to console cleaning, infection prevention teams often focus on process controls around ECMO patients: aseptic technique for sampling ports, standardized dressing change procedures at cannulation sites, and minimizing unnecessary circuit access. These controls are not “device cleaning” in the narrow sense, but they strongly influence infection outcomes associated with extracorporeal support.

Disinfection vs. sterilization (general distinction)

• Sterilization is typically applied to packaged disposables during manufacturing (e.g., oxygenators, circuits, cannulas). End users generally do not sterilize these components.
• Disinfection is typically the facility responsibility for the reusable console and non-sterile accessories (cables, external mounts), using hospital-approved disinfectants and contact times.

High-touch points to prioritize

• Touchscreen, knobs, buttons, and alarm silence controls
• Handles, pole clamps, and equipment cart surfaces
• Power cords, battery compartments (external surfaces), and cable connectors
• Gas fittings and sweep gas tubing connection points (external surfaces)
• Any area frequently handled during emergencies (clamps, circuit holders)

Example cleaning workflow (non-brand-specific)

• Don appropriate PPE per policy and treat surfaces as contaminated.
• Remove visible soil using approved wipes, then apply disinfectant with the required wet contact time.
• Wipe in one direction where possible and avoid re-contaminating cleaned areas.
• Pay attention to crevices and the underside of handles and mounts.
• Allow surfaces to dry, then inspect for residue, damage, or loose fittings.
• Document cleaning completion, any damage found, and any device removed from service for inspection.

If your ECMO workflow includes external temperature management equipment, ensure that its cleaning and water management (if applicable) follows its own IFU and your infection prevention team’s guidance.

A final practical point: disposal and transport of used circuits must be treated as a biohazard pathway. Programs often clamp and cap circuit ends before removal, use leak-resistant containment, and define who is responsible for final disposal documentation to reduce spill risk and protect staff.

Medical Device Companies & OEMs

In ECMO, procurement often involves more than picking a brand name. Understanding who manufactures what—and who is responsible for regulatory compliance and service—is essential for quality and uptime.

Manufacturer vs. OEM (Original Equipment Manufacturer)

• A manufacturer (in the regulatory sense) is the entity responsible for the finished medical device placed on the market, including compliance, labeling, post-market surveillance, and safety corrective actions.
• An OEM may produce components or subassemblies (for example, pumps, sensors, connectors, or electronics) that are incorporated into the final system.
• OEM relationships can be invisible to end users, but they affect spare parts availability, software/firmware compatibility, and service documentation.

How OEM relationships impact quality, support, and service

• Service responsiveness: if critical components are OEM-sourced, repair timelines may depend on upstream availability.
• Change control: component substitutions can occur over product life; hospitals should track versions and compatibility.
• Training and documentation: the party providing field training may be the manufacturer or an authorized service organization; clarify scope and escalation routes.
• Recall management: clear traceability (serial/lot tracking) helps identify whether your unit includes affected components.

Increasingly, ECMO programs also consider software lifecycle and cybersecurity as part of device governance. Even when a console is not network-connected, software updates can change alarm behavior, default settings, or data export functions. Hospitals often benefit from formal configuration control: documenting software versions, update dates, and any policy decisions about when updates may be applied (for example, not during peak seasonal ICU demand without testing).

Top 5 World Best Medical Device Companies / Manufacturers

The list below is presented as example industry leaders often associated with extracorporeal life support, perfusion, and adjacent critical care portfolios. It is not a verified ranking, and availability varies by country and regulatory approvals.

1. Getinge
   Getinge is widely recognized in critical care and surgical ecosystems and is commonly associated with extracorporeal support platforms in many markets. Its broader portfolio presence in hospital equipment can simplify service coordination and enterprise procurement for some health systems. Product configurations, monitoring options, and transport readiness vary by manufacturer and model. Buyers typically evaluate Getinge offerings alongside service network strength and disposable supply reliability in their region.

2. LivaNova
   LivaNova is known for cardiopulmonary and cardiac care-related technologies in many regions, with extracorporeal support products appearing in some ECMO and perfusion workflows. Hospitals often consider LivaNova where cardiac surgery programs already use related equipment and disposables. As with all vendors, the practical differentiators tend to be local clinical support, training capacity, and spare-parts logistics rather than console specifications alone. Regional availability and exact product lines can change over time.

3. Terumo
   Terumo has a strong global reputation across cardiovascular and hospital consumables, and its perfusion and extracorporeal product families are used in many countries. In ECMO procurement, Terumo is often evaluated for oxygenator and circuit options, supply consistency, and compatibility with local clinical practice. Support models can differ across countries depending on direct presence versus distributor-led arrangements. Buyers typically assess total cost of ownership driven by disposables and service.

4. Medtronic
   Medtronic is a large global medical device company with broad cardiovascular and critical care relevance. In ECMO programs, Medtronic may be encountered through components and related perfusion technologies, depending on the market and facility setup. Hospitals with existing cardiovascular purchasing relationships sometimes consider alignment benefits (service processes, contracting frameworks), but ECMO-specific offerings and configurations vary by manufacturer and country. Verification of local regulatory clearance and service scope is essential.

5. Fresenius Medical Care (including Xenios, where available)
   Fresenius Medical Care is globally known for renal therapies and related extracorporeal technologies, and in some markets Xenios-branded extracorporeal support solutions are part of its portfolio. Facilities considering these systems often focus on the robustness of the extracorporeal platform, training availability, and the maturity of local service infrastructure. Because corporate structures and regional product availability evolve, procurement teams should confirm who the legal manufacturer is in their jurisdiction and who provides field service. As always, compatibility with existing ICU workflows and consumable supply resilience are key.

Vendors, Suppliers, and Distributors

ECMO purchasing rarely happens as a simple one-time transaction. Understanding who is selling, who is stocking, and who is responsible for support protects uptime and patient safety.

Role differences between vendor, supplier, and distributor

• Vendor: a general term for a company that sells products to your facility; it may be a manufacturer, distributor, or reseller.
• Supplier: often refers to an entity that provides goods (and sometimes services) under contract; in ECMO this frequently includes disposables and accessories.
• Distributor: typically holds inventory, manages importation/customs (where applicable), and delivers products locally; may provide first-line technical support if authorized.

For ECMO, confirm whether the seller is an authorized channel. Unauthorized channels can create major risks: unclear traceability, limited warranty coverage, inability to access software updates, and delayed field safety notices.

Beyond authorization, procurement teams often clarify inventory model and responsibilities for expirations. ECMO disposables can be high-cost and time-sensitive; clear agreements about consignment stock, stock rotation, and returns for near-expiry items can reduce waste while protecting readiness.

Top 5 World Best Vendors / Suppliers / Distributors

The list below is presented as example global distributors with broad healthcare supply chain footprints. It is not a verified ranking, and these companies may not distribute ECMO systems in every country or may do so only through specific business units or partners.

1. McKesson
   McKesson is widely known for large-scale healthcare distribution and supply chain services in certain markets. For high-acuity medical equipment, buyer interest often centers on contract management, logistics performance, and integration with hospital procurement systems. Whether ECMO-related products are handled directly varies by region and authorization status. Hospitals typically still rely on the manufacturer or authorized service organizations for ECMO-specific training and technical service.

2. Cardinal Health
   Cardinal Health is commonly associated with broad medical and laboratory distribution and hospital supply services. In complex device categories, its value is often in standardized purchasing workflows, reliable fulfillment, and portfolio breadth. ECMO systems themselves are frequently managed through manufacturer-led channels, with distributors supporting consumables and adjacent ICU supplies depending on country. Always confirm authorization, traceability, and service handoff processes.

3. Medline
   Medline is widely recognized for hospital consumables and supply chain programs and operates across multiple regions. For ECMO programs, Medline may be relevant for ICU consumables, infection prevention products, and logistics support rather than the ECMO console itself (varies by market). Buyers often evaluate how distributor-led standardization can reduce variability in high-touch supplies used around ECMO patients. Contracting and service scope should be defined clearly.

4. Owens & Minor
   Owens & Minor is known for healthcare logistics and distribution services in some markets. From an operations perspective, distributors like this can support inventory management and continuity planning for critical supplies. ECMO-specific components and consoles usually require manufacturer authorization, so hospitals should clarify the boundary between distribution and technical support. Service escalation pathways should be documented before go-live.

5. DKSH
   DKSH is recognized in parts of Asia and other regions for market expansion services and healthcare distribution. In countries with higher import dependence, distributors can be pivotal for regulatory navigation, customs handling, and local stocking strategies. For ECMO, buyers should confirm whether DKSH (or any distributor) is authorized for the specific brand/model and whether it can support field service coordination. Strong distributor performance is often measured by lead times, training coordination, and post-market communication discipline.

Global Market Snapshot by Country

Before looking at individual countries, a common cross-market pattern is that ECMO growth tends to follow three enabling factors: (1) ICU expansion and staffing pipelines, (2) stronger cardiac surgery and interventional cardiology ecosystems, and (3) reliable importation or domestic manufacturing of disposables. Where any one of these is weak—especially staffing and service—programs may exist but remain limited to a few high-resource referral centers.

India

Demand is concentrated in private tertiary hospitals and large public institutes, driven by critical care expansion and high-acuity referral patterns. Many systems and disposables are imported, making uptime sensitive to supply chain planning and service coverage in major metros. Access outside large urban centers is uneven, and program success often hinges on training pipelines and standardized protocols. Cost sensitivity can also influence procurement strategy, with some facilities prioritizing robust disposable availability and service coverage over premium feature sets.

China

Demand is supported by large hospital networks, expanding ICU capacity, and increasing domestic manufacturing capability alongside imports. Service ecosystems are stronger in tier-1 cities, with variable access in smaller regions. Procurement frequently considers local regulatory requirements, distributor reach, and the ability to secure consistent disposable supply. Some centers evaluate domestic options to reduce dependency on international logistics, especially for high-burn consumables.

United States

Adoption is supported by mature critical care infrastructure, established ECMO centers, and a sizeable service/transport ecosystem. Programs often emphasize governance, reporting, and quality improvement, with strong expectations for 24/7 support and rapid parts availability. Market dynamics include high attention to total cost of ownership, reimbursement context, and staffing models. Many hospitals also maintain structured contracts for on-site training, rapid replacement equipment, and documented service level commitments.

Indonesia

Demand is growing in large urban hospitals, but access is limited outside major cities due to staffing and infrastructure constraints. Import dependence can affect lead times for disposables and service parts, making inventory planning critical. Facilities often prioritize systems with strong local training and authorized service presence. Program sustainability may depend on reliable inter-island logistics for urgent consumable replenishment.

Pakistan

ECMO capability is typically concentrated in a small number of tertiary centers, often in major cities, with significant dependence on imports and specialized staff. Service coverage and consumable availability can be limiting factors, so procurement teams often focus on distributor reliability and training commitments. Rural access remains limited, and patient transfer logistics shape demand.

Nigeria

Use is largely concentrated in a small number of high-resource private or flagship centers, with substantial constraints related to infrastructure, funding, and trained personnel. Import dependence and variable service coverage can increase downtime risk without strong local support agreements. Market growth is closely tied to critical care investment and stable supply chains in major urban areas.

Brazil

Demand is driven by large urban hospitals and established cardiac and critical care programs, with variability across states and between public and private sectors. Importation, regulatory pathways, and distributor capability influence product availability and service responsiveness. Training and standardized protocols are key differentiators for sustainable program growth.

Bangladesh

ECMO availability is generally concentrated in major city tertiary hospitals, with expanding interest as ICU capacity grows. Imports dominate many system components, and supply continuity for disposables can be a key operational risk. Program development often depends on partnerships for training and robust biomedical support.

Russia

Demand is concentrated in major urban centers with specialized cardiac and critical care services, while regional access can be uneven. Import dependence, procurement structures, and service logistics can materially affect uptime. Facilities often evaluate local service capability and parts availability alongside device performance.

Mexico

Use is most common in large tertiary centers, with private-sector investment supporting many programs. Imports are common, and service ecosystem maturity varies by region, making authorized support networks important. Urban-rural access gaps mean referral pathways and transport capability influence demand patterns.

Ethiopia

ECMO availability is limited and typically restricted to a small number of highly specialized centers, with substantial infrastructure and training barriers. Import dependence and constrained service resources increase the importance of simplified workflows, strong training, and reliable parts access. Urban concentration is pronounced, and scale-up depends on broader critical care investment.

Japan

Japan has advanced critical care and cardiovascular services, supporting a structured environment for extracorporeal support technologies. Procurement decisions often emphasize quality systems, reliability, and long-term service performance. Access is strongest in major centers, with strong expectations for training, documentation, and device lifecycle management.

Philippines

Demand is concentrated in large urban hospitals, with program growth influenced by private investment and critical care expansion. Importation is common, and continuity of disposables and service coverage can be challenging outside major hubs. Facilities often seek vendor support that includes training, protocols, and responsive technical service.

Egypt

ECMO use is centered in tertiary hospitals in major cities, supported by expanding ICU and cardiac services. Import dependence and variability in service infrastructure place emphasis on strong distributor/manufacturer support and inventory planning. Access outside urban centers is limited, making referral networks important.

Democratic Republic of the Congo

Availability is very limited, constrained by infrastructure, funding, and specialized workforce capacity. Import dependence and logistics challenges can make consistent supply and maintenance difficult. Where programs exist, they are typically concentrated in major urban areas and rely heavily on external support and robust operational planning.

Vietnam

Demand is increasing in larger urban hospitals as ICU capacity and specialized training expand. Imports remain significant, and procurement often prioritizes reliable service networks and consumable availability. Urban concentration is typical, with gradual diffusion as training programs mature.

Iran

Use is generally concentrated in larger tertiary centers with advanced cardiac and critical care services. Import constraints and supply chain complexity can influence availability of disposables and parts, making local support strategies essential. Program sustainability often depends on consistent training and maintenance capability.

Turkey

Demand is supported by a mix of public and private tertiary hospitals, with strong urban centers and established critical care services. Importation remains important for many systems and disposables, and buyers often evaluate vendor training and service responsiveness carefully. Regional access is variable, with best capability concentrated in major cities.

Germany

Germany has a mature ECMO landscape with strong ICU infrastructure and established clinical governance in many centers. Procurement often emphasizes compliance, documented performance, and integrated service support. Access is broad in urban and regional hospitals, though high-volume expertise still clusters in specialized centers.

Thailand

Demand is concentrated in large urban hospitals and medical tourism-associated centers, with gradual expansion of critical care capability. Import dependence makes authorized distribution and service agreements important for uptime. Access outside major cities remains limited, so referral and transport pathways influence utilization.

Key Takeaways and Practical Checklist for Extracorporeal membrane oxygenation ECMO system

• Treat ECMO as a program (people + protocols + equipment), not just a purchase.
• Confirm your Extracorporeal membrane oxygenation ECMO system model is cleared for use in your country.
• Standardize a complete bill of materials so “missing small parts” never delays initiation.
• Separate what is single-use disposable vs reusable console accessories in your inventory system.
• Build a staffing model that guarantees 24/7 trained coverage, including surges and sick leave.
• Require structured onboarding plus annual competency validation for every ECMO role.
• Use simulation drills for air entrainment, pump failure, oxygen supply loss, and transport events.
• Keep a documented escalation tree with direct contacts for biomedical engineering and the manufacturer.
• Verify console preventive maintenance status before placing any unit into clinical service.
• Track serial and lot numbers for console, oxygenator, circuit, and cannulas for traceability.
• Use pre-use checklists that include power, battery status, alarms, and sensor calibration status.
• Confirm sweep gas supply strategy for bedside use and for transport (including cylinder backups).
• Position the console to minimize line tension and reduce accidental dislodgement risk.
• Route tubing to avoid kinks, sharp bends, and pinch points from bed rails or wheels.
• Treat device values as trend indicators and always correlate with patient assessment and labs.
• Configure alarms per policy and document any temporary changes with time and reason.
• Implement structured handoffs that include line tracing and circuit inspection at the bedside.
• Plan transport pathways (elevators, doors, power outlets) before moving an ECMO patient.
• Stock critical spares based on risk assessment (oxygenator, pump head, clamps, cables).
• Define who has authority to change settings and who documents every change.
• Use a consistent troubleshooting sequence: patient first, circuit second, console third.
• Train staff to recognize and respond to suction events, abnormal pressures, and low-flow states.
• Treat unexplained increases in resistance or delta pressure as a prompt for structured evaluation.
• Maintain a cleaning protocol that is compatible with the console IFU and infection control policy.
• Disinfect high-touch points (screen, knobs, handles, cables) between cases and as scheduled.
• Prevent fluid ingress by wiping (not spraying) and protecting vents and connectors.
• Ensure biohazard disposal pathways for blood-contacting disposables are always available.
• Clarify warranty terms, service response times, and software update responsibilities in contracts.
• Confirm whether service is manufacturer-direct or through an authorized third party in your region.
• Include training hours, on-site go-live support, and refresher sessions in procurement scope.
• Monitor consumable usage rates and set par levels that reflect worst-case surge conditions.
• Use incident reporting and post-event debriefs to continuously improve ECMO safety controls.
• Coordinate with lab, imaging, blood bank, and transport teams to avoid operational bottlenecks.
• Build dashboards for uptime, alarm events, consumable burn rate, and training compliance.
• Document configuration control so firmware/software changes do not introduce hidden variability.
• Require clear labeling and standardized storage to prevent mixing incompatible disposables.
• Align ECMO governance with ethics, triage, and resource allocation frameworks where applicable.
• Plan end-of-life and disposal processes for consoles as part of lifecycle management.
• Validate documentation workflows so device logs, patient monitors, and lab timestamps support reliable incident review.
• Include distributor/manufacturer agreements for inventory rotation to reduce expiries while maintaining readiness.
• Standardize a “first-hour on ECMO” checklist to confirm cannula securement, alarm status, and baseline trend documentation.
• Define an emergency plan for power transitions (AC to battery and back) during transport and imaging workflows.
• Ensure multidisciplinary orientation for non-ECMO staff who frequently enter the room (radiology, housekeeping, transport, security).

If you are looking for contributions and suggestion for this content please drop an email to info@mymedicplus.com